GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy

Authors: Sun, Peng, Wei, Peng, Liu, Hongliang, Wu, Jia, Gross, Neil D., Sikora, Andrew G., Wei, Qingyi, Shete, Sanjay, Zafereo, Mark E., Liu, Jisheng, Li, Guojun

Source: In eBioMedicine August 2023 94

Outcomes for recurrent oral cavity squamous cell carcinoma

Authors: Contrera, Kevin J. ^{a, 1}, Zafereo, Mark E. ^{a, 1, ⁎}, Yaniv, Dan ^a, Roberts, Diane B. ^a, Gillenwater, Ann M. ^a, Hanna, Ehab Y. ^a, Weber, Randal S. ^a, Myers, Jeffrey N. ^a, Chang, Edward I. ^b, Garvey, Patrick B. ^b, Hanasono, Matthew M. ^b, Yu, Peirong ^b, Hutcheson, Katherine A. ^{a, c}, Fuller, Clifton D. ^c, Tyler, Matthew A. ^d, Neskey, David M. ^e

Source: In Oral Oncology November 2022 134

ACR Appropriateness Criteria® Parathyroid Adenoma

Authors: Zander, David, Bunch, Paul M., Policeni, Bruno, Juliano, Amy F., Carneiro-Pla, Denise, Dubey, Prachi, Gule-Monroe, Maria K., Hagiwara, Mari, Hoang, Jenny K., Jain, Vikas, Kim, Lawrence T., Moonis, Gul, Parsons, Matthew S., Rath, Tanya J., Solórzano, Carmen C., Subramaniam, Rathan M., Taheri, M. Reza, DuChene Thoma, Kate, Trout, Andrew T., Zafereo, Mark E., Jr., Corey, Amanda S.

Source: In Journal of the American College of Radiology November 2021 18(11) Supplement:S406-S422

Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine.

Authors: Castellanos, Luz E, Zafereo, Mark E, Sturgis, Erich M, Wang, Jennifer R, Ying, Anita K, Waguespack, Steven G

Source: Journal of Clinical Endocrinology & Metabolism; Feb2025, Vol. 110 Issue 2, pe208-e217, 10p

Subject Terms: IODINE isotopes, LYMPHATIC metastasis, PAPILLARY carcinoma, THYROID cancer, SURGICAL pathology

The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma.

Authors: Wang, Jennifer R, Zafereo, Mark E, Cabanillas, Maria E, Wu, Chia Chin, Xu, Li, Dai, Yaoyi, Wang, Wenyi, Lai, Stephen Y, Henderson, Ying, Erasmus, Lauren, Williams, Michelle D, Joshu, Corinne, Ray, Debashree

Source: Journal of Clinical Endocrinology & Metabolism; Feb2025, Vol. 110 Issue 2, p356-363, 8p

Subject Terms: PROPORTIONAL hazards models, SURVIVAL rate, OVERALL survival, PAPILLARY carcinoma, THYROID cancer

Polygenic Score for Clinicopathologic Features and Survival Outcomes in Papillary Thyroid Carcinoma.

Authors: Li, Sophie, Zheng, Guibin, Xu, Li, Goswami, Maitrayee, Zafereo, Mark E., Sherman, Steven I., Li, Guojun, Sturgis, Erich M., Wang, Jennifer R.

Source: JAMA Otolaryngology-Head & Neck Surgery; Feb2025, Vol. 151 Issue 2, p113-120, 8p

Recurrent Poorly Differentiated Thyroid Cancer Successfully Treated With Radiation and Immunotherapy.

Authors: Hamidi, Sarah, Ning, Matthew S, Phan, Jack, Zafereo, Mark E, Gule-Monroe, Maria K, Dadu, Ramona

Source: JCEM Case Reports; Feb2025, Vol. 33 Issue 2, p1-5, 5p

Subject Terms: IMMUNE checkpoint inhibitors, EXTERNAL beam radiotherapy, SKULL base, THYROID cancer, CANCER treatment, STEREOTACTIC radiosurgery, IODINE isotopes, CETUXIMAB

Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma.

Authors: Hamidi, Sarah, Yedururi, Sireesha, Hu, Mimi I., Busaidy, Naifa L., Sherman, Steven I., Jimenez, Camilo, Grubbs, Elizabeth G., Maniakas, Anastasios, Zafereo, Mark E., Subbiah, Vivek, Waguespack, Steven G.

Source: Thyroid; Jan2025, Vol. 35 Issue 1, p6-17, 12p

Subject Terms: MEDULLARY thyroid carcinoma, PROTEIN-tyrosine kinases, ALANINE aminotransferase, ASPARTATE aminotransferase

Parathyroid cancer: An update

Authors: Rodrigo, Juan P., Hernandez-Prera, Juan C., Randolph, Gregory W., Zafereo, Mark E., Hartl, Dana M., Silver, Carl E., Suárez, Carlos, Owen, Randall P., Bradford, Carol R., Mäkitie, Antti A., Shaha, Ashok R., Bishop, Justin A., Rinaldo, Alessandra, Ferlito, Alfio

Source: In Cancer Treatment Reviews June 2020 86

Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement.

Authors: Hamidi, Sarah, Dadu, Ramona, Zafereo, Mark E., Ferrarotto, Renata, Wang, Jennifer R., Maniakas, Anastasios, Gunn, G. Brandon, Lee, Anna, Spiotto, Michael T., Iyer, Priyanka C., Sousa, Luana G., Akhave, Neal S., Ahmed, Salmaan, Learned, Kim O., Lu, Charles, Lai, Stephen Y., Williams, Michelle, Hosseini, S. Mohsen, Busaidy, Naifa L., Cabanillas, Maria E.

Source: JAMA Oncology; Sep2024, Vol. 10 Issue 9, p1264-1271, 8p

Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades.

Authors: Hensley, Sarah G, Hu, Mimi I, Bassett, Roland L, Ying, Anita K, Zafereo, Mark E, Perrier, Nancy D, Busaidy, Naifa L, Hyde, Samuel M, Grubbs, Elizabeth G, Waguespack, Steven G

Source: Journal of Clinical Endocrinology & Metabolism; Sep2024, Vol. 109 Issue 9, p2256-2268, 13p

Subject Terms: MEDULLARY thyroid carcinoma, SYMPTOMS, OLDER patients, OVERALL survival, FAMILY history (Medicine), CHILD patients

Thyroid Disease Around the World

Authors: Maniakas, Anastasios, Davies, Louise, Zafereo, Mark E.

Source: In Otolaryngologic Clinics of North America June 2018 51(3):631-642

Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer

Authors: Kamal, Mona, Ng, Sweet Ping, Eraj, Salman A., Rock, Crosby D., Pham, Brian, Messer, Jay A., Garden, Adam S., Morrison, William H., Phan, Jack, Frank, Steven J., El-Naggar, Adel K., Johnson, Jason M., Ginsberg, Lawrence E., Ferrarotto, Renata, Lewin, Jan S., Hutcheson, Katherine A., Cardenas, Carlos E., Zafereo, Mark E., Lai, Stephen Y., Hessel, Amy C., Weber, Randal S., Gunn, G. Brandon, Fuller, Clifton D., Mohamed, Abdallah S.R., Rosenthal, David I.

Source: In Oral Oncology April 2018 79:1-8

Recovery of Recurrent Laryngeal Nerve Function With Neoadjuvant Treatment: Neural Characterization.

Authors: Russell, Marika D., Abdelhamid Ahmed, Amr H., Feng, Zipei, Shonka, David C., Karcioglu, Amanda S., Iwata, Ayaka J., Kyriazidis, Natalia, Siddiqui, Sameer H., Athni, Tejas S., Park, Jong C., Wirth, Lori J., Zafereo, Mark E., Randolph, Gregory W.

Source: Laryngoscope; Jul2024, Vol. 134 Issue 7, p3415-3419, 5p

Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy.

Authors: Turner, Naimah, Hamidi, Sarah, Ouni, Rim, Rico, Rene, Henderson, Ying C., Puche, Maria, Alekseev, Sayan, Colunga-Minutti, Jocelynn G., Zafereo, Mark E., Lai, Stephen Y., Kim, Sang T., Cabanillas, Maria E., Nurieva, Roza

Source: Frontiers in Immunology; 2024, p01-18, 18p

Subject Terms: THYROID cancer, ANAPLASTIC thyroid cancer, IMMUNOTHERAPY, IODINE isotopes, HAIR transplantation, KINASE inhibitors

Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease Aggressiveness.

Authors: Shirali, Aditya S, Hu, Mimi I, Chiang, Yi-Ju, Graham, Paul H, Fisher, Sarah B, Sosa, Julie Ann, Perrier, Nancy, Brown, Spandana, Holla, Vijaykumar R, Dadu, Ramona, Busaidy, Naifa, Sherman, Steven I, Cabanillas, Maria, Waguespack, Steven G, Zafereo, Mark E, Grubbs, Elizabeth G

Source: Journal of the Endocrine Society; Jun2024, Vol. 8 Issue 6, p1-11, 11p

Subject Terms: NUCLEOTIDE sequencing, SOMATIC mutation, MEDULLARY thyroid carcinoma, CANCER patients, OVERALL survival

Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus

Authors: Zafereo, Mark E., Xu, Li, Dahlstrom, Kristina R., Viamonte, Carlo A., El-Naggar, Adel K., Wei, Qingyi, Li, Guojun, Sturgis, Erich M.

Source: In Oral Oncology May 2016 56:47-53

TGF-β1 and TGF-βR1 variants are associated with clinical outcomes in smoking-related head and neck cancer patients treated with chemoradiation through modulating microRNA-mediated regulation.

Authors: Niu, Zihao, Sun, Peng, Zafereo, Mark E., Liu, Hongliang, Wei, Peng, Wu, Jia, Gross, Neil D., Shete, Sanjay, Wei, Qingyi, Zheng, Guibin, Sikora, Andy G., Calin, George A., Li, Guojun

Source: Cancer Immunology, Immunotherapy; May2024, Vol. 73 Issue 5, p1-13, 13p

Subject Terms: HEAD & neck cancer, CANCER patients, CHEMORADIOTHERAPY, TREATMENT effectiveness, GENETIC variation

Poorly differentiated thyroid carcinomas: conceptual controversy and clinical impact.

Authors: Coca-Pelaz, Andrés, Rodrigo, Juan P., Agaimy, Abbas, Williams, Michelle D., Saba, Nabil F., Nuyts, Sandra, Randolph, Gregory W., López, Fernando, Vander Poorten, Vincent, Kowalski, Luiz P., Civantos, Francisco J., Zafereo, Mark E., Mäkitie, Antti A., Cohen, Oded, Nixon, Iain J., Rinaldo, Alessandra, Ferlito, Alfio

Source: Virchows Archiv: European Journal of Pathology; May2024, Vol. 484 Issue 5, p733-742, 10p

Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF^V600E-Mutated Anaplastic Thyroid Carcinoma.

Authors: Hamidi, Sarah, Iyer, Priyanka C., Dadu, Ramona, Gule-Monroe, Maria K., Maniakas, Anastasios, Zafereo, Mark E., Wang, Jennifer R., Busaidy, Naifa L., Cabanillas, Maria E.

Source: Thyroid; Mar2024, Vol. 34 Issue 3, p336-346, 11p

Subject Terms: ANAPLASTIC thyroid cancer, IMMUNOTHERAPY, THERAPEUTICS, PROGRESSION-free survival, OVERALL survival, SURGICAL excision